middl
east
respiratori
syndrom
mer
emerg
caus
sever
respiratori
ill
march
case
mer
report
includ
diseas
present
rang
asymptomat
infect
sever
respiratori
ill
multiorgan
failur
acut
hypoxem
respiratori
failur
ahrf
develop
hospit
patient
mer
associ
high
date
specif
antivir
therapi
mer
proven
effect
support
therapi
remain
cornerston
manag
noninvas
ventil
increasingli
use
manag
ahrf
variabl
niv
may
initi
avoid
need
intub
invas
mechan
ventil
mv
sever
studi
report
high
failur
rate
need
invas
ventil
among
patient
sever
acut
respiratori
distress
syndrom
ard
associ
increas
recent
analysi
lung
safe
studi
unselect
patient
ard
niv
associ
higher
intens
care
unit
icu
mortal
patient
ratio
partial
pressur
oxygen
fraction
inspir
oxygen
lower
mm
role
niv
ahrf
secondari
viral
respiratori
infect
unclear
although
uncontrol
studi
suggest
niv
effect
safe
manag
patient
sever
acut
respiratori
syndrom
sar
other
highlight
concern
increas
transmiss
risk
healthcar
worker
patient
sar
treat
use
niv
ahrf
caus
pandem
viru
infect
report
sever
report
niv
failur
reach
studi
limit
retrospect
natur
often
small
sampl
size
noninvas
ventil
use
patient
valu
prevent
intub
impact
clinic
outcom
studi
object
studi
assess
success
niv
mer
patient
ahrf
avoid
intub
associ
mortal
icu
hospit
length
stay
secondari
object
identifi
factor
associ
niv
failur
mer
patient
conduct
analysi
multicent
retrospect
cohort
critic
ill
mer
patient
particip
tertiari
care
hospit
citi
saudi
arabia
admit
septemb
octob
institut
review
board
particip
center
approv
studi
inform
consent
requir
due
observ
natur
studi
detail
descript
cohort
describ
mer
defin
presenc
posit
revers
chain
reaction
upper
lower
respiratori
studi
includ
patient
ahrf
requir
mechan
ventil
support
icu
whether
invas
noninvas
patient
manag
initi
niv
compar
manag
invas
mv
without
niv
analysi
extract
baselin
data
includ
demograph
comorbid
durat
onset
symptom
emerg
room
admiss
icu
admiss
intub
arteri
blood
gase
sever
ill
measur
sequenti
organ
failur
assess
sofa
laboratori
radiograph
find
collect
day
icu
admiss
primari
outcom
mortal
icu
hospit
length
stay
collect
durat
noninvas
invas
mechan
ventil
day
base
observ
also
calcul
compar
two
group
use
oxygen
rescu
therapi
includ
neuromuscular
blockad
oscil
ventil
extracorpor
membran
oxygen
ecmo
nitric
oxid
prone
posit
continu
variabl
describ
median
interquartil
rang
mean
standard
deviat
test
use
u
student
test
appropri
categor
variabl
report
frequenc
proport
test
use
test
fisher
exact
test
compar
niv
patient
invas
mv
patient
baselin
characterist
collect
variabl
icu
cours
measur
clinic
outcom
curv
censor
day
plot
test
use
compar
surviv
time
patient
treat
niv
invas
mv
imbal
baselin
characterist
niv
patient
invas
mv
patient
develop
propens
score
treat
niv
follow
covari
use
propens
score
model
develop
age
sofa
score
admiss
icu
chronic
pulmonari
diseas
chronic
cardiac
diseas
chronic
neurolog
diseas
diabet
chronic
complic
ratio
glasgow
coma
scale
examin
abil
propens
score
account
baselin
characterist
carri
propens
score
adjust
comparison
baselin
characterist
assess
independ
associ
niv
mortal
multivari
logist
regress
model
adjust
propens
score
cluster
center
also
assess
associ
niv
mortal
subgroup
patient
ratio
test
interact
perform
secondari
comparison
patient
fail
niv
success
treat
niv
statist
test
signific
set
analys
conduct
use
sa
version
sa
institut
cari
nc
critic
ill
mer
patient
patient
requir
ventilatori
support
includ
analysi
niv
use
initi
ventilatori
mode
patient
invas
mv
initi
ventilatori
mode
patient
demograph
baselin
characterist
critic
ill
patient
mer
infect
requir
niv
compar
invas
mv
present
tabl
icu
day
patient
initi
institut
niv
like
lower
sofa
score
baselin
compar
patient
requir
invas
mv
median
compar
p
median
number
quadrant
infiltr
chest
radiograph
significantli
lower
among
niv
patient
compar
invas
mv
patient
compar
p
median
gc
significantli
higher
among
niv
patient
compar
invas
mv
patient
compar
p
ratio
partial
pressur
oxygen
arteri
blood
fraction
inspir
oxygen
ratio
icu
day
differ
niv
group
invas
mv
group
compar
p
physiolog
paramet
day
admiss
icu
present
tabl
adjust
propens
score
differ
baselin
characterist
insignific
patient
manag
initi
niv
niv
use
median
durat
day
patient
eventu
requir
intub
invas
mv
tabl
although
sofa
score
lower
among
patient
initi
institut
niv
compar
invas
mv
day
score
similar
group
figur
patient
manag
initi
niv
like
requir
nitric
oxid
subsequ
compar
invas
mv
patient
vs
p
although
oxygen
rescu
therapi
differ
tabl
crude
mortal
lower
niv
group
compar
p
tabl
adjust
use
propens
score
niv
associ
mortal
ci
p
surviv
analysi
day
show
differ
mortal
figur
signific
associ
niv
mortal
subgroup
patient
ratio
ci
p
ci
p
respect
p
valu
interact
tabl
differ
serial
ratio
time
figur
median
icu
hospit
length
stay
similar
niv
patient
invas
mv
patient
day
compar
day
p
day
compar
day
p
signific
differ
durat
invas
mv
total
durat
niv
invas
mv
two
group
although
invas
day
total
niv
invas
day
significantli
longer
among
niv
patient
compar
invas
mv
patient
tabl
figur
overal
niv
patient
avoid
subsequ
intub
tabl
patient
significantli
younger
fail
niv
median
age
year
vs
year
p
much
lower
baselin
sofa
score
median
sofa
vs
p
tabl
crude
mortal
significantli
higher
patient
fail
niv
compar
patient
success
treat
niv
tabl
figur
shown
among
patient
ahrf
niv
commonli
use
nearli
alway
result
subsequ
transit
invas
ventil
result
suggest
initi
niv
use
mer
patient
associ
reduct
mortal
length
icu
hospit
stay
patient
greater
requir
subsequ
inhal
nitric
oxid
minor
patient
success
manag
young
less
sever
diseas
find
import
implic
earli
manag
patient
infect
mer
specif
littl
advantag
initi
niv
treatment
patient
ahrf
niv
may
associ
greater
subsequ
need
oxygen
rescu
therapi
inhal
nitric
oxid
noninvas
ventil
proven
use
mean
avoid
intub
improv
clinic
outcom
certain
condit
gener
possibl
rather
rapid
revers
respiratori
exampl
pulmonari
edema
due
congest
heart
failur
respiratori
failur
due
copd
condit
typic
worsen
improv
rang
mani
hour
eg
caus
pneumonia
appear
littl
advantag
use
niv
mean
avoid
choos
use
niv
initi
treatment
patient
hypoxem
respiratori
failur
practic
risk
patient
worsen
niv
requir
intub
time
alreadi
advanc
organ
failur
studi
assess
effect
niv
patient
ahrf
secondari
ard
acut
lung
injuri
overal
effect
niv
reduc
intub
rate
improv
clinic
outcom
patient
remain
post
hoc
analysi
lung
safe
studi
found
niv
use
patient
ard
associ
higher
icu
mortal
subset
patient
sever
random
control
trial
patient
ahrf
show
niv
effect
reduc
intub
rate
compar
high
flow
standard
oxygen
therapi
associ
higher
howev
may
import
differ
care
outcom
accord
niv
interfac
exampl
nasal
nose
mouth
full
face
helmet
niv
gener
recommend
patient
hypoxia
secondari
respiratori
infect
due
lack
efficaci
potenti
pathogen
also
consid
one
procedur
may
increas
risk
transmiss
healthcar
broad
dispers
exhal
air
niv
via
face
mask
previous
shown
use
simul
patient
although
niv
success
use
small
number
sar
patient
without
document
nosocomi
studi
show
niv
might
led
increas
nosocomi
cohort
niv
failur
strikingli
high
associ
requir
inhal
nitric
oxid
howev
import
note
process
respons
higher
requir
inhal
nitric
oxid
patient
treat
niv
could
relat
time
transit
niv
invas
mechan
ventil
ie
transit
delay
rather
use
niv
per
se
final
confid
interv
around
point
estim
associ
initi
niv
mortal
wide
therefor
real
differ
entir
exclud
either
direct
howev
given
high
failur
rate
data
therefor
indic
use
niv
patient
mer
gener
avoid
unless
use
patient
least
sever
ill
studi
certain
strength
largest
cohort
examin
ventil
practic
among
critic
ill
patient
mer
contain
detail
demograph
baselin
characterist
physiolog
intervent
outcom
studi
also
subject
sever
limit
due
retrospect
natur
studi
detail
set
niv
eg
peep
drive
pressur
data
patient
toler
type
niv
mask
interfac
nasal
mask
use
niv
reason
intub
data
address
associ
niv
vs
invas
ventil
subsequ
nosocomi
pneumonia
studi
design
address
infect
control
issu
relat
niv
risk
transmiss
healthcar
worker
therefor
report
outcom
import
healthcar
worker
patient
although
adjust
imbal
baselin
characterist
use
propens
score
effect
residu
unmeasur
confound
exclud
given
retrospect
natur
studi
potenti
effect
indic
bia
exist
exampl
data
show
less
sever
ill
patient
reflect
sofa
like
manag
niv
nevertheless
account
sofa
propens
score
residu
bia
exist
would
like
favor
show
better
outcom
niv
make
find
conserv
estim
potenti
risk
associ
niv
addit
potenti
bia
exist
patient
receiv
niv
may
present
less
advanc
diseas
diseas
may
mere
progress
niv
point
patient
advanc
alreadi
present
requir
invas
ventil
outset
due
limit
number
patient
avoid
intub
power
identifi
independ
predictor
niv
success
conclus
report
result
niv
use
mer
patient
larg
cohort
critic
ill
patient
observ
littl
advantag
initi
niv
treatment
patient
ahrf
niv
may
associ
greater
subsequ
need
oxygen
rescu
therapi
author
conflict
interest
disclos
bma
concept
design
data
acquisit
analyt
plan
interpret
data
work
draft
manuscript
critic
revis
manuscript
import
intellectu
content
approv
final
version
publish
agreement
account
aspect
work
iq
fh
ym
gm
ao
ak
aa
kk
ss
aam
os
ama
rr
ar
hb
ah
ms
ht
data
acquisit
critic
revis
manuscript
import
intellectu
content
approv
final
version
publish
agreement
account
aspect
work
jj
concept
design
analyt
plan
data
analysi
critic
revis
manuscript
import
intellectu
content
approv
final
version
publish
agreement
account
aspect
work
lm
fgh
raf
ya
concept
design
analyt
plan
interpret
data
work
critic
revis
manuscript
import
intellectu
content
approv
final
version
publish
agreement
account
aspect
work
